These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 16288373)

  • 1. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.
    Vandepapeliere P; Barrasso R; Meijer CJ; Walboomers JM; Wettendorff M; Stanberry LR; Lacey CJ
    J Infect Dis; 2005 Dec; 192(12):2099-107. PubMed ID: 16288373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of human papillomavirus types in anogenital warts of men.
    Chan PK; Luk AC; Luk TN; Lee KF; Cheung JL; Ho KM; Lo KK
    J Clin Virol; 2009 Feb; 44(2):111-4. PubMed ID: 19097933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun; 16(89):91-4. PubMed ID: 17582921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.
    Garland SM; Steben M; Sings HL; James M; Lu S; Railkar R; Barr E; Haupt RM; Joura EA
    J Infect Dis; 2009 Mar; 199(6):805-14. PubMed ID: 19199546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
    Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
    Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts.
    Lacey CJ; Thompson HS; Monteiro EF; O'Neill T; Davies ML; Holding FP; Fallon RE; Roberts JS
    J Infect Dis; 1999 Mar; 179(3):612-8. PubMed ID: 9952367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
    Villa LL; Ault KA; Giuliano AR; Costa RL; Petta CA; Andrade RP; Brown DR; Ferenczy A; Harper DM; Koutsky LA; Kurman RJ; Lehtinen M; Malm C; Olsson SE; Ronnett BM; Skjeldestad FE; Steinwall M; Stoler MH; Wheeler CM; Taddeo FJ; Yu J; Lupinacci L; Railkar R; Marchese R; Esser MT; Bryan J; Jansen KU; Sings HL; Tamms GM; Saah AJ; Barr E
    Vaccine; 2006 Jul; 24(27-28):5571-83. PubMed ID: 16753240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
    Garland SM; Hernandez-Avila M; Wheeler CM; Perez G; Harper DM; Leodolter S; Tang GW; Ferris DG; Steben M; Bryan J; Taddeo FJ; Railkar R; Esser MT; Sings HL; Nelson M; Boslego J; Sattler C; Barr E; Koutsky LA;
    N Engl J Med; 2007 May; 356(19):1928-43. PubMed ID: 17494926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.
    Komloš KF; Kocjan BJ; Košorok P; Luzar B; Meglič L; Potočnik M; Hočevar-Boltežar I; Gale N; Seme K; Poljak M
    J Med Virol; 2012 Aug; 84(8):1233-41. PubMed ID: 22711351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases.
    Villa LL
    Vaccine; 2006 Mar; 24 Suppl 1():S23-8. PubMed ID: 16194583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human papillomavirus vaccine.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):65-6. PubMed ID: 16977280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
    Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
    Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of general human papillomavirus vaccination in sexually active women].
    Hampl M
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S95-9. PubMed ID: 19353480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
    Olsson SE; Villa LL; Costa RL; Petta CA; Andrade RP; Malm C; Iversen OE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E
    Vaccine; 2007 Jun; 25(26):4931-9. PubMed ID: 17499406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of human papillomavirus genotypes and viral loads in anogenital warts.
    Ball SL; Winder DM; Vaughan K; Hanna N; Levy J; Sterling JC; Stanley MA; Goon PK
    J Med Virol; 2011 Aug; 83(8):1345-50. PubMed ID: 21678438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.
    Klencke B; Matijevic M; Urban RG; Lathey JL; Hedley ML; Berry M; Thatcher J; Weinberg V; Wilson J; Darragh T; Jay N; Da Costa M; Palefsky JM
    Clin Cancer Res; 2002 May; 8(5):1028-37. PubMed ID: 12006515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infections and vulvar disease development.
    Garland SM; Insinga RP; Sings HL; Haupt RM; Joura EA
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1777-84. PubMed ID: 19505910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).
    Aubin F; Prétet JL; Jacquard AC; Saunier M; Carcopino X; Jaroud F; Pradat P; Soubeyrand B; Leocmach Y; Mougin C; Riethmuller D;
    Clin Infect Dis; 2008 Sep; 47(5):610-5. PubMed ID: 18637758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine.
    Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E
    Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.